A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158)
Clinical trial NCT01583647 · TERMINATED
Trial details
- NCT number
- NCT01583647
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2012-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.